106 related articles for article (PubMed ID: 10357044)
1. A naturalistic comparison of adverse effects between slow titration and loading of divalproex sodium in psychiatric inpatients.
Lima WJ; Dopheide JA; Kramer BA; Earhart CA; Wincor MZ
J Affect Disord; 1999; 52(1-3):261-7. PubMed ID: 10357044
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of switching psychiatric patients from a delayed-release to an extended-release formulation of divalproex sodium.
Horne RL; Cunanan C
J Clin Psychopharmacol; 2003 Apr; 23(2):176-81. PubMed ID: 12640219
[TBL] [Abstract][Full Text] [Related]
3. Assessment of patient preference and side effects in patients switched from divalproex sodium delayed release to divalproex sodium extended release.
Minirth FB; Neal V
J Clin Psychopharmacol; 2005 Feb; 25(1):99-101. PubMed ID: 15643111
[No Abstract] [Full Text] [Related]
4. Tolerability of oral loading of divalproex sodium in the treatment of acute mania.
Martinez JM; Russell JM; Hirschfeld RM
Depress Anxiety; 1998; 7(2):83-6. PubMed ID: 9614597
[TBL] [Abstract][Full Text] [Related]
5. The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder.
Hirschfeld RM; Baker JD; Wozniak P; Tracy K; Sommerville KW
J Clin Psychiatry; 2003 Jul; 64(7):841-6. PubMed ID: 12934987
[TBL] [Abstract][Full Text] [Related]
6. Risperidone does not affect steady-state pharmacokinetics of divalproex sodium in patients with bipolar disorder.
Ravindran A; Silverstone P; Lacroix D; van Schaick E; Vermeulen A; Alexander J
Clin Pharmacokinet; 2004; 43(11):733-40. PubMed ID: 15301577
[TBL] [Abstract][Full Text] [Related]
7. Extended-release divalproex sodium for mood stabilization.
Stoner SC; Dubisar BM; Lea JW; Marken PA; Ramlatchman LV; Reynolds JB
Pharmacotherapy; 2004 Sep; 24(9):1147-53. PubMed ID: 15460175
[TBL] [Abstract][Full Text] [Related]
8. Drug-Drug Interaction Studies of Paliperidone and Divalproex Sodium Extended-Release Tablets in Healthy Participants and Patients with Psychiatric Disorders.
Remmerie B; Ariyawansa J; De Meulder M; Coppola D; Berwaerts J
J Clin Pharmacol; 2016 Jun; 56(6):683-92. PubMed ID: 26412032
[TBL] [Abstract][Full Text] [Related]
9. Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127).
Suppes T; Vieta E; Liu S; Brecher M; Paulsson B;
Am J Psychiatry; 2009 Apr; 166(4):476-88. PubMed ID: 19289454
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind, placebo-controlled study of divalproex extended release loading monotherapy in ambulatory bipolar spectrum disorder patients with moderate-to-severe hypomania or mild mania.
McElroy SL; Martens BE; Creech RS; Welge JA; Jefferson L; Guerdjikova AI; Keck PE
J Clin Psychiatry; 2010 May; 71(5):557-65. PubMed ID: 20361901
[TBL] [Abstract][Full Text] [Related]
11. Extended-release divalproex sodium for patients with side effects from delayed-release divalproex sodium.
Longo LP
Am J Psychiatry; 2005 Aug; 162(8):1548-9. PubMed ID: 16055790
[No Abstract] [Full Text] [Related]
12. Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts.
Suppes T; Kroger H; Pikalov A; Loebel A
J Psychiatr Res; 2016 Jul; 78():86-93. PubMed ID: 27089521
[TBL] [Abstract][Full Text] [Related]
13. Tolerability of oral loading of divalproex sodium in child psychiatry inpatients.
Good CR; Feaster CS; Krecko VF
J Child Adolesc Psychopharmacol; 2001; 11(1):53-7. PubMed ID: 11322746
[TBL] [Abstract][Full Text] [Related]
14. Mood stabilizer loading versus titration in acute mania: audit of clinical practice.
Wheeler A; Robinson G; Fraser A
Aust N Z J Psychiatry; 2008 Nov; 42(11):955-62. PubMed ID: 18941960
[TBL] [Abstract][Full Text] [Related]
15. The adverse effect profile and efficacy of divalproex sodium compared with valproic acid: a pharmacoepidemiology study.
Zarate CA; Tohen M; Narendran R; Tomassini EC; McDonald J; Sederer M; Madrid AR
J Clin Psychiatry; 1999 Apr; 60(4):232-6. PubMed ID: 10221283
[TBL] [Abstract][Full Text] [Related]
16. Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients.
Hirschfeld RM; Allen MH; McEvoy JP; Keck PE; Russell JM
J Clin Psychiatry; 1999 Dec; 60(12):815-8. PubMed ID: 10665626
[TBL] [Abstract][Full Text] [Related]
17. Tolerability of divalproex sodium in elderly psychiatric patients with mixed diagnoses.
Puryear LJ; Kunik ME; Workman R
J Geriatr Psychiatry Neurol; 1995 Oct; 8(4):234-7. PubMed ID: 8561838
[TBL] [Abstract][Full Text] [Related]
18. Valproic acid for agitation in dementia.
Lonergan ET; Cameron M; Luxenberg J
Cochrane Database Syst Rev; 2004; (2):CD003945. PubMed ID: 15106227
[TBL] [Abstract][Full Text] [Related]
19. A study of the safety, efficacy, and tolerability of switching from the standard delayed release preparation of divalproex sodium to the extended release formulation in patients with schizophrenia.
Citrome L; Tremeau F; Wynn PS; Roy B; Dinakar H
J Clin Psychopharmacol; 2004 Jun; 24(3):255-9. PubMed ID: 15118478
[TBL] [Abstract][Full Text] [Related]
20. A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania.
McElroy SL; Keck PE; Stanton SP; Tugrul KC; Bennett JA; Strakowski SM
J Clin Psychiatry; 1996 Apr; 57(4):142-6. PubMed ID: 8601548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]